An update from Plus Therapeutics (PSTV) is now available.
Plus Therapeutics, Inc. recently took advantage of their established margin loan facility with Pershing LLC, borrowing $3.3 million to settle their existing debt with Oxford Finance, LLC. By repaying the Oxford Term Loan in full, the company has not only cleared the outstanding principal and interest but also terminated Oxford’s security interest in its assets and lifted various restrictions and covenants associated with the loan. This strategic financial move could signal a new phase of operational freedom for the company.
For a thorough assessment of PSTV stock, go to TipRanks’ Stock Analysis page.
